Archive forFebruary, 2009

Bipolar disorder seems both asset, hindrance to Christian artist’s … - Walla Walla Union-Bulletin

Bipolar disorder seems both asset, hindrance to Christian artist’s … - Walla Walla Union-Bulletin
WALLA WALLA LeRoy Heavirland does his artwork for reasons other than sales or fame, he said during an interview. Heavirland said that he also suffers from bipolar disorder. He explained that often people who have that illness are very creative …

Comments

Doctor scrutinized for drug-firm ties gets kudos from bipolar patients … - Boston Globe

Doctor scrutinized for drug-firm ties gets kudos from bipolar patients … - Boston Globe
“Emergency - Andrew.” Marcie Lipsitt found that all she had to do was page Dr. Joseph Biederman or another doctor on his pediatric psychiatry team with that message, and she would get a call back within two minutes to help her through her son Andrew …

Comments

Death Rates Due To Medical Illness Linked To Bipolar Disorder - Med India

Death Rates Due To Medical Illness Linked To Bipolar Disorder - Med India
A new study has shown that bipolar disorders increase the risk of early death from a medical illness. For the study, the researchers comprehensively reviewed 17 studies involving more than 331,000 patients. They found that people with bipolar …

Comments

“Guyver: The Bio Boosted Armor” or “The Bipolar Awesome” Without Mark … - News.toonzone.net

“Guyver: The Bio Boosted Armor” or “The Bipolar Awesome” Without Mark … - News.toonzone.net
Sho is just your regular, nondescript high school student, until he and a friend find a mysterious device in the woods. When it bonds to Sho, he becomes the Guyver by yelling its name. The Chronos Corporation wants the device, and will do anything to …

Comments

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the … - Yahoo Finance

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the … - Yahoo Finance
TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ — Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional information regarding the company’s …

Comments

FDA Issues Complete Response Letter for RISPERDAL CONSTA for … - Businesswire.com

FDA Issues Complete Response Letter for RISPERDAL CONSTA for … - Businesswire.com
CAMBRIDGE, Mass.–( BUSINESS WIRE )–Alkermes, Inc. (NASDAQ: ALKS) today announced that the Food and Drug Administration (FDA) has asked Alkermes partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), for additional …

Comments

FDA Issues Complete Response Letter For RISPERDAL(R) CONSTA(R) For The … - Medical News Today

FDA Issues Complete Response Letter For RISPERDAL(R) CONSTA(R) For The … - Medical News Today
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced that the Food and Drug Administration (FDA) has asked for additional information regarding the company’s supplemental New Drug Application (sNDA) for RISPERDAL(R …

Comments

The International a bipolar thriller - Union-Recorder

The International a bipolar thriller - Union-Recorder
The International is a lot like a sandwich with bipolar disorder; the bread is stale but the meat, in between, has a nice burst of flavor. I think that is a mixed metaphor, but I will stand by it. I think it paints the write picture. (A corny …

Comments